FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002786908> ?p ?o ?g. }

• W2002786908 endingPage "86" @default.
• W2002786908 startingPage "77" @default.
• W2002786908 abstract "Background: Generally, chemotherapeutic drugs attack on both normal and tumor cells non-specifically causing life threatening side effects, necessitating targeted drug delivery to tumors.Purpose: The purpose of this study is to formulate albumin-based nanoparticles for tumor targeted drug delivery and noninvasive diagnosis.Methods: Albumin based nanoparticles (NPs) were developed as a potential tumor theragnostic agent by entrapping an anti cancer drug, doxorubicin and a near infrared dye, indocyanine green. Theragnostic nanoparticles were prepared using a well established coacervation/nanoprecipitation method followed by lyophilization. The formulation was optimized by varying process parameters using full factorial design of experiments. Release of dye and drug from NPs and physical state of the drug in NPs was studied using DSC. The NPs were injected into tumor bearing mice intravenously and imaged using a bio-imager.Results: The optimized nanoparticle formulation had a particle size of 125.0 ± 1.8 nm, poly dispersity index of 0.180 ± 0.057 and zeta potential of −32.7 ± 0.9 mV. The release of dye and drug from the nanoparticles was determined to be quasi-fickian diffusion mediated. Differential scanning calorimetry (DSC) studies revealed the stability of drug in the NP. The in-vivo studies showed enhanced accumulation of the dye loaded NPs at the tumor site than the dye solution, thus allowing noninvasive tumor monitoring.Conclusion: These results project the newly proposed and evaluated nanoparticle formulation as a potential tumor targeting and imaging delivery system." @default.
• W2002786908 created "2016-06-24" @default.
• W2002786908 creator A5013708028 @default.
• W2002786908 creator A5020104945 @default.
• W2002786908 creator A5067063269 @default.
• W2002786908 creator A5074179435 @default.
• W2002786908 date "2012-10-05" @default.
• W2002786908 modified "2023-09-29" @default.
• W2002786908 title "Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting" @default.
• W2002786908 cites W147439079 @default.
• W2002786908 cites W1903778810 @default.
• W2002786908 cites W1951612395 @default.
• W2002786908 cites W1977072597 @default.
• W2002786908 cites W1980122435 @default.
• W2002786908 cites W1980535921 @default.
• W2002786908 cites W1983845908 @default.
• W2002786908 cites W1984590186 @default.
• W2002786908 cites W1991263563 @default.
• W2002786908 cites W1998464224 @default.
• W2002786908 cites W1999626926 @default.
• W2002786908 cites W2008156029 @default.
• W2002786908 cites W2015230924 @default.
• W2002786908 cites W2017718367 @default.
• W2002786908 cites W2023177796 @default.
• W2002786908 cites W2029753193 @default.
• W2002786908 cites W2031057579 @default.
• W2002786908 cites W2032760352 @default.
• W2002786908 cites W2038375609 @default.
• W2002786908 cites W2046606679 @default.
• W2002786908 cites W2050181086 @default.
• W2002786908 cites W2061655961 @default.
• W2002786908 cites W2061877572 @default.
• W2002786908 cites W2072954285 @default.
• W2002786908 cites W2078458130 @default.
• W2002786908 cites W2082902103 @default.
• W2002786908 cites W2086130473 @default.
• W2002786908 cites W2094011365 @default.
• W2002786908 cites W2097631047 @default.
• W2002786908 cites W2108961184 @default.
• W2002786908 cites W2109802668 @default.
• W2002786908 cites W2132005699 @default.
• W2002786908 cites W2143510926 @default.
• W2002786908 cites W2149978263 @default.
• W2002786908 cites W2273495465 @default.
• W2002786908 doi "https://doi.org/10.3109/1061186x.2012.729214" @default.
• W2002786908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23036042" @default.
• W2002786908 hasPublicationYear "2012" @default.
• W2002786908 type Work @default.
• W2002786908 sameAs 2002786908 @default.
• W2002786908 citedByCount "38" @default.
• W2002786908 countsByYear W20027869082012 @default.
• W2002786908 countsByYear W20027869082013 @default.
• W2002786908 countsByYear W20027869082014 @default.
• W2002786908 countsByYear W20027869082015 @default.
• W2002786908 countsByYear W20027869082016 @default.
• W2002786908 countsByYear W20027869082017 @default.
• W2002786908 countsByYear W20027869082018 @default.
• W2002786908 countsByYear W20027869082019 @default.
• W2002786908 countsByYear W20027869082020 @default.
• W2002786908 countsByYear W20027869082021 @default.
• W2002786908 countsByYear W20027869082022 @default.
• W2002786908 countsByYear W20027869082023 @default.
• W2002786908 crossrefType "journal-article" @default.
• W2002786908 hasAuthorship W2002786908A5013708028 @default.
• W2002786908 hasAuthorship W2002786908A5020104945 @default.
• W2002786908 hasAuthorship W2002786908A5067063269 @default.
• W2002786908 hasAuthorship W2002786908A5074179435 @default.
• W2002786908 hasConcept C11432220 @default.
• W2002786908 hasConcept C121332964 @default.
• W2002786908 hasConcept C126511603 @default.
• W2002786908 hasConcept C142724271 @default.
• W2002786908 hasConcept C150903083 @default.
• W2002786908 hasConcept C155672457 @default.
• W2002786908 hasConcept C171250308 @default.
• W2002786908 hasConcept C178790620 @default.
• W2002786908 hasConcept C185592680 @default.
• W2002786908 hasConcept C192562407 @default.
• W2002786908 hasConcept C207001950 @default.
• W2002786908 hasConcept C2779820397 @default.
• W2002786908 hasConcept C2781065829 @default.
• W2002786908 hasConcept C39519442 @default.
• W2002786908 hasConcept C71924100 @default.
• W2002786908 hasConcept C86181022 @default.
• W2002786908 hasConcept C86803240 @default.
• W2002786908 hasConcept C97355855 @default.
• W2002786908 hasConceptScore W2002786908C11432220 @default.
• W2002786908 hasConceptScore W2002786908C121332964 @default.
• W2002786908 hasConceptScore W2002786908C126511603 @default.
• W2002786908 hasConceptScore W2002786908C142724271 @default.
• W2002786908 hasConceptScore W2002786908C150903083 @default.
• W2002786908 hasConceptScore W2002786908C155672457 @default.
• W2002786908 hasConceptScore W2002786908C171250308 @default.
• W2002786908 hasConceptScore W2002786908C178790620 @default.
• W2002786908 hasConceptScore W2002786908C185592680 @default.
• W2002786908 hasConceptScore W2002786908C192562407 @default.
• W2002786908 hasConceptScore W2002786908C207001950 @default.
• W2002786908 hasConceptScore W2002786908C2779820397 @default.
• W2002786908 hasConceptScore W2002786908C2781065829 @default.

• next